Özet
This study was financially supported by Turkish Scientific and Research Council (Tübitak) Project no: 214M100. In the present thesis study, it was aimed to investigate the potential of proliferation and osteogenic differentiation of human mesenchymal stem cells (hMSCs) in perfusion bioreactors.
In the first step of this study, chitosan-hydroxyapatite superporous hydrogel (chitosan-HA SPHC) scaffolds were prepared by using sodium bicarbonate (NaHCO3) as a foaming agent and glyoxal as a cross-linking agent. The microwave assisted gas foaming technique has produced tissue scaffolds that are faster to obtain, in high yield and higher reproducibility in vitro studies.
In the second step of the experimental study, the installation of the perfusion bioreactor system, in which leakage and diffusion problems can be solved and which provides sustainable sterility through long-term dynamic culture studies has been completed. At the next stage of the study, dynamic cell culture studies were carried out for 21 days using hMSCs at different flow velocities and tissue scaffolds of different sizes (P3D-6: 0.1 mL/min, P3D-6:0.2 mL/min; P3D-10: 0.27 mL/min) and media changes were made on certain days (days 3, 6, 9, 12, 15 and 18) of the culture. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide) analysis was performed to observe viability and proliferation of cells on certain days of cell culture studies. SEM (Scanning Electron Microscopy) analysis was performed to observe cell morphologies and penetrations. At the end of the cell culture studies, RT-PCR (Real Time Polymerase Chain Reaction) analyzes were performed to determine the expression levels of Collagen1 (Col1), Runt Associated Transcription Factor 2 (RUNX2), Osteocalcin (OCN) and Osteopontin (OPN) genes in hMSCs.
In the last part of the thesis study, flow and mass transfer simulation studies were carried out in the perfusion bioreactor using COMSOL software. The accuracy of the model was tested with models developed for low and high flow rates in a bioreactor without a tissue scaffold and in the presence of a non-porous tissue scaffold. Affterwards the flow model and mass transfer model in perfusion bioreactor in the presence of a permeable tissue scaffold took place. The results obtained from the Computational Fluid Dynamics (CFD) modeling studies conducted within the scope of the thesis seem to support the experimental findings.
In the light of all these analyzes and findings, it has been shown that the dynamic culture approach performed with P3D-6 scaffolds at 0.1 mL/min and 0.2 mL/min flow rates support the osteogenic differentiation of hMSCs in the perfusion bioreactor. In addition, it can be seen that the CFD approach is the decisive factor in achieving successful results in vitro production of engineered bone grafts when different operating parameters are considered
This study was financially supported by Turkish Scientific and Research Council (Tübitak) Project no: 214M100. In the present thesis study, it was aimed to investigate the potential of proliferation and osteogenic differentiation of human mesenchymal stem cells (hMSCs) in perfusion bioreactors. In the first step of this study, chitosan-hydroxyapatite superporous hydrogel (chitosan-HA SPHC) scaffolds were prepared by using sodium bicarbonate (NaHCO3) as a foaming agent and glyoxal as a cross-linking agent. The microwave assisted gas foaming technique has produced tissue scaffolds that are faster to obtain, in high yield and higher reproducibility in vitro studies. In the second step of the experimental study, the installation of the perfusion bioreactor system, in which leakage and diffusion problems can be solved and which provides sustainable sterility through long-term dynamic culture studies has been completed. At the next stage of the study, dynamic cell culture studies were carried out for 21 days using hMSCs at different flow velocities and tissue scaffolds of different sizes (P3D-6: 0.1 mL/min, P3D-6:0.2 mL/min; P3D-10: 0.27 mL/min) and media changes were made on certain days (days 3, 6, 9, 12, 15 and 18) of the culture. MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide) analysis was performed to observe viability and proliferation of cells on certain days of cell culture studies. SEM (Scanning Electron Microscopy) analysis was performed to observe cell morphologies and penetrations. At the end of the cell culture studies, RT-PCR (Real Time Polymerase Chain Reaction) analyzes were performed to determine the expression levels of Collagen1 (Col1), Runt Associated Transcription Factor 2 (RUNX2), Osteocalcin (OCN) and Osteopontin (OPN) genes in hMSCs. In the last part of the thesis study, flow and mass transfer simulation studies were carried out in the perfusion bioreactor using COMSOL software. The accuracy of the model was tested with models developed for low and high flow rates in a bioreactor without a tissue scaffold and in the presence of a non-porous tissue scaffold. Affterwards the flow model and mass transfer model in perfusion bioreactor in the presence of a permeable tissue scaffold took place. The results obtained from the Computational Fluid Dynamics (CFD) modeling studies conducted within the scope of the thesis seem to support the experimental findings. In the light of all these analyzes and findings, it has been shown that the dynamic culture approach performed with P3D-6 scaffolds at 0.1 mL/min and 0.2 mL/min flow rates support the osteogenic differentiation of hMSCs in the perfusion bioreactor. In addition, it can be seen that the CFD approach is the decisive factor in achieving successful results in vitro production of engineered bone grafts when different operating parameters are considered
Künye
[1] Lee, Na Kyung, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 130.3: 456-469, 2007.
[2] Stevens, M., Biomaterials for bone tissue engineering, Materials Today, 11,18-25, 2008.
[3] Neovius, E., & Engstrand, T. Craniofacial reconstruction with bone andbiomaterials: Review over the last 11 years. Journal of Plastic, Reconstructive and Aesthetic Surgery, 63, 1615–1623, 2010.
[4] Holtorf, Heidi L., John A. Jansen, and Antonios G. Mikos. Modulation of cell differentiation in bone tissue engineering constructs cultured in a bioreactor. Tissue Engineering. Springer US, 225-241, 2006.
[5] Gaspar, Diana Alves, Viviane Gomide, and Fernando Jorge Monteiro. The role of perfusion bioreactors in bone tissue engineering. Biomatter 2.4: 167-175, 2012.
[6] Yu, Xiaojun, et al. Bioreactor-based bone tissue engineering: the influence of dynamic flow on osteoblast phenotypic expression and matrix mineralization. Proceedings of the National Academy of Sciences of the United States of America 101.31: 11203-11208, 2004.
[7] Hill, Nicola M., J. Geoffrey Horne, and Peter A. Devane. Donor site morbidity in the iliac crest bone graft. Australian and New Zealand Journal of Surgery 69.10: 726-728, 1999.
[8] Seiler 3rd, J. G., and J. Johnson. Iliac crest autogenous bone grafting: donor site complications. Journal of the Southern Orthopaedic Association 9.2: 91-97, 1999.
[9] Perez-Sanchez, M. J., Ramirez-Glindon, E., Lledo-Gil, M., Calvo-Guirado, J. L., &Perez- Sanchez, C. Biomaterials for bone regeneration. Medicina OralPatologia Oral y Cirugia Bucal, 15, 517–522, 2010.
[10] Garg, T., Singh, O., Arora, S., & Murthy, R. Scaffold: A novel carrier for celland drug delivery. Critical Reviews in Therapeutic Drug Carrier Systems 29, 1–63, 2012.
[11] Stodolak-Zych, E., Szumera, M., & Blazewicz, M. Osteoconductive nanocomposite materials for bone regeneration. Materials Science Forum, 730–732, 38–43, 2012.
[12] Barradas, A. M. C., Yuan, H., van Blitterswijk, C. A., & Habibovic, P. Osteoinductive biomaterials: Current knowledge of properties, experimental models and biological mechanisms. European Cells and Materials 21, 407–429, 2011.
[13] Fröhlich, Mirjam, et al. Bone grafts engineered from human adipose-derived stem cells in perfusion bioreactor culture. Tissue Engineering Part A 16.1: 179-189, 2009.
[14] Vunjak-Novakovic G, Meinel L, Altman G, Kaplan D: Bioreactor cultivation of osteochondral grafts. Orthod Craniofac Res, 8:209-218, 2005.
[15] Marolt, Darja, Miomir Knezevic, and Gordana Vunjak-Novakovic. Bone tissue engineering with human stem cells. Stem Cell Research & Therapy 1.2: 10, 2010.
[16] Mygind T, Stiehler M, Baatrup A, Li H, Zou X, Flyvbjerg A, Kassem M, Bunger C: Mesenchymal stem cell ingrowth and diff erentiation on coralline hydroxyapatite scaffolds. Biomaterials, 28:1036-1047, 2010.
[17] Boukhechba, Florian, et al. Human primary osteocyte differentiation in a 3D culture system. Journal of Bone and Mineral Research 24.11: 1927-1935, 2009.
[18] Turhani, Dritan, et al. Three‐dimensional composites manufactured with human mesenchymal cambial layer precursor cells as an alternative for sinus floor augmentation: an in vitro study. Clinical Oral Implants Research 16.4: 417-424, 2005.
[19] Meinel, Lorenz, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Annals of Biomedical Engineering 32.1: 112-122, 2004.
[20] Chesnutt, Betsy M., et al. Composite chitosan/nano-hydroxyapatite scaffolds induce osteocalcin production by osteoblasts in vitro and support bone formation in vivo. Tissue Engineering Part A 15.9: 2571-2579, 2009.
[21] Hofmann, Sandra, et al. Control of in vitro tissue-engineered bone-like structures using human mesenchymal stem cells and porous silk scaffolds. Biomaterials 28.6: 1152-1162, 2007.
[22] Dalby, Matthew J., et al. The control of human mesenchymal cell differentiation using nanoscale symmetry and disorder. Nature Materials 6.12: 997-1003, 2007.
[23] Comisar, Wendy A., et al. Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. Biomaterials 28.30: 4409-4417, 2007.
[24] Engler, Adam J., et al. Matrix elasticity directs stem cell lineage specification. Cell 126.4 : 677-689, 2006.
[25] Karageorgiou, Vassilis, et al. Porous silk fibroin 3‐D scaffolds for delivery of bone morphogenetic protein‐2 in vitro and in vivo. Journal of Biomedical Materials Research Part A 78.2: 324-334, 2006.
[26] Chao, Pen-hsiu Grace, Warren Grayson, and Gordana Vunjak-Novakovic. Engineering cartilage and bone using human mesenchymal stem cells. Journal of Orthopaedic Science 12.4: 398, 2007.
[27] Grayson, Warren L., et al. Effects of initial seeding density and fluid perfusion rate on formation of tissue-engineered bone. Tissue Engineering Part A 14.11: 1809-1820, 2008.
[28] Sikavitsas, Vassilios I., et al. Mineralized matrix deposition by marrow stromal osteoblasts in 3D perfusion culture increases with increasing fluid shear forces. Proceedings of the National Academy of Sciences 100.25: 14683-14688, 2003.
[30] Sittichockechaiwut, Anuphan, et al. Use of rapidly mineralising osteoblasts and short periods of mechanical loading to accelerate matrix maturation in 3D scaffolds. Bone 44.5: 822-829, 2009.
[31] Hutmacher, Dietmar W., and Harmeet Singh. Computational fluid dynamics for improved bioreactor design and 3D culture. Trends in Biotechnology 26.4: 166-172, 2008.
[32] Gercek Beskardes, I., Comparison of different bioreactor performances for osteogenic differentiation of mesenchymal stem cells. Doctoral Disseration, Hacettepe University Institute of Natural and Applied Sciences, Ankara, 2014.
[33] Cinbiz, M.N., Tigli, R.S., Beskardes, I.G., Gumusderelioglu, M., Colak, U., Computational fluid dynamics modeling of momentum transport in rotating wall perfused bioreactor for cartilage tissue engineering, Journal of Biotechnology, 150, 389-95, 2010.
[34] Mravic, Marco, Bruno Péault, and Aaron W. James. Current trends in bone tissue engineering. BioMed Research International, 2014.
[35] Gümüşderelioğlu, M., Doku Mühendisliğinin Ürünleri. Bilim ve Teknik Dergisi, 2010.
[36] Amini, A.R., Laurencin, C.T., Nukavarapu, S.P., Bone tissue engineering: recent advances and challenges, Critical reviews in Biomedical Engineering, 40, 363-408, 2012.
[37] Zimmermann, C.E., Borner, B.I., Hasse, A., Sieg, P., Donor site morbidity after microvascular fibula transfer, Clinical Oral Investigations, 5, 214-9, 2001.
[38] Agarwal, R., García, J.A., Biomaterial strategies for engineering implants for enhanced osseointegration and bone repair, Advanced Drug Delivery Reviews, 12756, 1-10, 2015.
[39] Wua, S., Xiangmei, L., Kelvin, W.K., Changsheng, Y., Xianjin, Y.L., Biomimetic porous scaffolds for bone tissue engineering, Materials Science and Engineering, 80, 1-36, 2014.
[40] Rodrigues, A.V.C, Fernandes, T.G., Diogo, M.M., Stem cell cultivation in bioreactors, Biotechnology Advances, 29, 815-829, 2011.
[41] Schofer, M.D., Tunnermann, L., Kaiser, H., Roessler, P.P., Theisen, C., Heverhagen, J.T., Hering, J., Voelker, M., Agarwal, S., Efe, T., Fuchs-Winkelmann, S., Paletta, R.J., Functionalisation of PLLA nanofiber scaffolds using a possible cooperative effect between collagen type I and BMP-2: impact on colonization and bone formation in vivo, Journal of Material Science, 2227-2233, 2012.
[42] Villalona, Gustavo A., et al. Cell-seeding techniques in vascular tissue engineering. Tissue Engineering Part B: Reviews 16.3: 341-350, 2010.
[43] Wendt, D., Timmins, N., Malda, J., Janssen, F., Ratcliffe, A., Vunjak- Novakovic, G., Martin, I. Bioreactors for tissue engineering. Tissue Engineering, 1st ed., (eds: Van Blitterswijk, C.A.,), Academic Press, Canada, 483-506, 2008.
[44] Griffon, D.J., Abulencia, J.P., Ragetly, G.R., Fredericks, L.P., Chaieb, S., A comparative study of seeding techniques and three-dimensional matrices for mesenchymal cell attachment. Journal of Tissue Engineering and Regenerative Medicine, 5, 169-79, 2011.
[45] Ellis, M., M. Jarman-Smith, and J. B. Chaudhuri. Bioreactor systems for tissue engineering: a four-dimensional challenge. Bioreactors for Tissue Engineering. Springer Netherlands, 1-18, 2005.
[46] Frost, H.M., Skeletal structural adaptations to mechanical usage (SATMU): 2. Redefining Wolff's law: the remodeling problem, The Anatomical Record, 226, 414-22, 1990.
[47] Chen, Ching-Yun, et al. 3D porous calcium-alginate scaffolds cell culture system improved human osteoblast cell clusters for cell therapy. Theranostics 5.6: 643, 2015.
[48] Jaasma, M.J., Plunkett, A.N., O’Brien, F.J., Design and validation of a dynamic flow perfusion bioreactor for use with compliant tissue engineering scaffolds, Journal of Biotechnology, 133, 490-496, 2008.
[49] Moffat, K.L., Neal, A.R., Freed, E.L., Guilak F., Engineering functional tissues: in vitro culture parameters, Principle of Tissue Engineering, (eds: Lanza, R., Langer, R., Vacanti, J.P.), Boston, 237-259, 2013.
[50] Bhumiratana, Sarindr, et al. Principles of bioreactor design for tissue engineering. Principles of Tissue Engineering: 261-78, 2013.
[51] Grayson, Warren L., et al. Optimizing the medium perfusion rate in bone tissue engineering bioreactors. Biotechnology and Bioengineering 108.5: 1159-1170, 2011.
[52] Yeatts, Andrew B., and John P. Fisher. Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone 48.2: 171-181, 2011.
[53] Salehi-Nik, Nasim, et al. Engineering parameters in bioreactor’s design: a critical aspect in tissue engineering. BioMed Research International, 2013.
[54] Godara, P., McFarland, C.D., Nordon, E.R., Design of bioreactors for mesenchymal stem cell tissue engineering, Journal of Chemical Technology Biotechnology, 408-420, 2008.
[55] Sladkova, Martina, and Giuseppe Maria de Peppo. Bioreactor systems for human bone tissue engineering. Processes 2.2: 494-525, 2014.
[56] El Haj, A.J., Cartmell, H.S., Bioreactors for bone tissue engineering, Journal of Engineering and Medicine, 1523-1532, 2010.
[57] Marijanovic, Inga, et al. Bioreactor-Based Bone Tissue Engineering. Advanced Techniques in Bone Regeneration. InTech, 2016.
[58] Tığlı, R. Seda, and Menemşe Gümüşderelioğlu. Chondrogenesis on BMP‐6 loaded chitosan scaffolds in stationary and dynamic cultures. Biotechnology and Bioengineering 104.3: 601-610, 2009.
[59] Sikavitsas, V.I., Bancroft, G.N., Mikos, A.G., Formation of three-dimensional cell/polymer constructs for bone tissue engineering in a spinner flask and a rotating wall vessel bioreactor, Journal of Biomedical Materials Research, 62, 136-48, 2002.
[60] Chen, Huang-Chi, and Yu-Chen Hu. Bioreactors for tissue engineering. Biotechnology Letters 28.18: 1415-1423, 2006.
[61] Bartnikowsk,i M., Klein, J.T., Melchels, F.P.W., Woodruf, M.A., Effects of scaffold architecture on mechanical characteristics and osteoblast response to static and perfusion bioreactor cultures, Biotechnology and Bioengineering, 1440-1451, 2014.
[62] Yeatts, Andrew B., et al. In vivo bone regeneration using tubular perfusion system bioreactor cultured nanofibrous scaffolds. Tissue Engineering Part A 20.1-2: 139-146, 2013.
[63] Kasper, F.K., Liao, J., Kretlow, J.D., Sikavitsas, V.I., Mikos, A.G., Flow perfusion culture of mesenchymal stem cells for bone tissue engineering, StemBook, 2008.
[64] Rauh, Juliane, et al. Bioreactor systems for bone tissue engineering. Tissue Engineering Part B: Reviews 17.4: 263-280, 2011.
[65] Yeatts, Andrew B., and John P. Fisher. Bone tissue engineering bioreactors: dynamic culture and the influence of shear stress. Bone 48.2: 171-181, 2011.
[66] Bancroft, Gregory N., et al. Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteoblasts in a dose-dependent manner. Proceedings of the National Academy of Sciences 99.20: 12600-12605, 2002.
[67] Datta, Néha, et al. In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation. Proceedings of the National Academy of Sciences of the United States of America 103.8: 2488-2493, 2006.
[68] Holtorf, Heidi L., et al. Flow perfusion culture of marrow stromal cells seeded on porous biphasic calcium phosphate ceramics. Annals of Biomedical Engineering 33.9: 1238-1248, 2005.
[69] Gomes, Manuela E., et al. Effect of flow perfusion on the osteogenic differentiation of bone marrow stromal cells cultured on starch‐based three‐dimensional scaffolds. Journal of Biomedical Materials Research Part A 67.1: 87-95, 2003.
[70] Gomes, Manuela E., et al. Influence of the porosity of starch-based fiber mesh scaffolds on the proliferation and osteogenic differentiation of bone marrow stromal cells cultured in a flow perfusion bioreactor. Tissue Engineering 12.4: 801-809, 2006.
[71] Holtorf, Heidi L., John A. Jansen, and Antonios G. Mikos. Flow perfusion culture induces the osteoblastic differentiation of marrow stromal cell‐scaffold constructs in the absence of dexamethasone. Journal of Biomedical Materials Research Part A 72.3 326-334, 2005.
[72] Sikavitsas, Vassilios I., et al. Flow perfusion enhances the calcified matrix deposition of marrow stromal cells in biodegradable nonwoven fiber mesh scaffolds. Annals of Biomedical Engineering 33.1: 63, 2005
[73] Gomes, Manuela E., et al. In vitro localization of bone growth factors in constructs of biodegradable scaffolds seeded with marrow stromal cells and cultured in a flow perfusion bioreactor. Tissue Engineering 12.1: 177-188, 2006.
[74] Alvarez-Barreto, Jose F., et al. Flow perfusion improves seeding of tissue engineering scaffolds with different architectures. Annals of Biomedical Engineering 35.3: 429-442, 2007.
[75] Alvarez‐Barreto, Jose F., and Vassilios I. Sikavitsas. Improved mesenchymal stem cell seeding on RGD‐modified poly (L‐lactic acid) scaffolds using flow perfusion. Macromolecular Bioscience 7.5: 579-588, 2007.
[76] Bjerre, Lea, et al. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds. Biomaterials 29.17: 2616-2627, 2008.
[77] Sikavitsas, Vassilios I., et al. Influence of the in vitro culture period on the in vivo performance of cell/titanium bone tissue‐engineered constructs using a rat cranial critical size defect model. Journal of Biomedical Materials Research Part A 67.3: 944-951, 2003.
[78] Grayson, Warren L., et al. Engineering anatomically shaped human bone grafts. Proceedings of the National Academy of Sciences 107.8: 3299-3304, 2010.
[79] Xie, Youzhuan, et al. Three-dimensional flow perfusion culture system for stem cell proliferation inside the critical-size β-tricalcium phosphate scaffold. Tissue Engineering 12.12: 3535-3543, 2006.
[81] Olivier, V., et al. In vitro culture of large bone substitutes in a new bioreactor: importance of the flow direction. Biomedical Materials 2.3: 174, 2007.
[82] Bernhardt, Anne, et al. Mineralised collagen—an artificial, extracellular bone matrix—improves osteogenic differentiation of bone marrow stromal cells. Journal of Materials Science: Materials in Medicine 19.1: 269-275, 2008.
[83] Pisanti, Paola, et al. Tubular perfusion system culture of human mesenchymal stem cells on poly‐L‐lactic acid scaffolds produced using a supercritical carbon dioxide‐assisted process. Journal of Biomedical Materials Research Part A 100.10: 2563-2572, 2012.
[84] Janssen, F. W., et al. Online measurement of oxygen consumption by goat bone marrow stromal cells in a combined cell‐seeding and proliferation perfusion bioreactor. Journal of Biomedical Materials Research Part A 79.2: 338-348, 2006.
[85] Janssen, Frank W., et al. A perfusion bioreactor system capable of producing clinically relevant volumes of tissue-engineered bone: in vivo bone formation showing proof of concept. Biomaterials 27.3: 315-323, 2006.
[86] Janssen, F. W., et al. Human tissue‐engineered bone produced in clinically relevant amounts using a semi‐automated perfusion bioreactor system: a preliminary study. Journal of Tissue Engineering and Regenerative Medicine 4.1: 12-24, 2010.
[87] Timmins, Nicholas E., et al. Three-dimensional cell culture and tissue engineering in a T-CUP (tissue culture under perfusion). Tissue engineering 13.8 2021-2028, 2007.
[88] Wendt, D., et al. Oscillating perfusion of cell suspensions through three‐dimensional scaffolds enhances cell seeding efficiency and uniformity. Biotechnology and Bioengineering 84.2: 205-214, 2003.
[89] Braccini, Alessandra, et al. Three‐dimensional perfusion culture of human bone marrow cells and generation of osteoinductive grafts. Stem Cells 23.8: 1066-1072, 2005.
[90] Cartmell, Sarah H., et al. Effects of medium perfusion rate on cell-seeded three-dimensional bone constructs in vitro. Tissue Engineering 9.6: 1197-1203, 2003.
[91] Porter, Blaise D., et al. Noninvasive image analysis of 3D construct mineralization in a perfusion bioreactor. Biomaterials 28.15: 2525-2533, 2007.
[92] Seitz, Sebastian, et al. Influence of in vitro cultivation on the integration of cell-matrix constructs after subcutaneous implantation. Tissue Engineering 13.5: 1059-1067, 2007.
[93] Volkmer, Elias, et al. Hypoxia in static and dynamic 3D culture systems for tissue engineering of bone. Tissue Engineering Part A 14.8: 1331-1340, 2008.
[94] Yang, Jinfeng, et al. Proliferation and osteogenesis of immortalized bone marrow‐derived mesenchymal stem cells in porous polylactic glycolic acid scaffolds under perfusion culture. Journal of Biomedical Materials Research Part A 92.3: 817-829, 2010.
[95] Zhao, Feng, and Teng Ma. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnology and Bioengineering 91.4: 482-493, 2005.
[96] Zhao, Feng, et al. Effects of oxygen transport on 3‐d human mesenchymal stem cell metabolic activity in perfusion and static cultures: Experiments and mathematical model. Biotechnology Progress 21.4: 1269-1280, 2005.
[97] Zhao, Feng, Ravindran Chella, and Teng Ma. Effects of shear stress on 3‐D human mesenchymal stem cell construct development in a perfusion bioreactor system: Experiments and hydrodynamic modeling. Biotechnology and Bioengineering 96.3: 584-595, 2007.
[98] Zhao, Feng, et al. Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds. Journal of Cellular Physiology 219.2: 421-429, 2009.
[99] Hosseinkhani, Hossein, et al. Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusion enhance in vitro DNA expression of mesenchymal stem cells. Tissue Engineering 11.9-10: 1459-1475, 2005.
[100] Hosseinkhani, Hossein, et al. Enhanced ectopic bone formation using a combination of plasmid DNA impregnation into 3-D scaffold and bioreactor perfusion culture. Biomaterials 27.8: 1387-1398, 2006.
[101] Hosseinkhani, Hossein, et al. Ectopic bone formation in collagen sponge self-assembled peptide–amphiphile nanofibers hybrid scaffold in a perfusion culture bioreactor. Biomaterials 27.29: 5089-5098, 2006.
[102] Wang, Yichao, et al. Application of perfusion culture system improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblastic cells in porous ceramic materials. Tissue Engineering 9.6: 1205-1214, 2003.
[103] COMSOL Multiphysics, Users Guide 2010, http://chemelab.ucsd.edu/ CAPE/comsol/Comsol_UserGuide.pdf (June 2016).
[104] Kuzmin, Dmitri. Introduction to computational fluid dynamics. University of Dortmund, Dortmund (2014).
[105] Chapra, Steven C., and Raymond P. Canale. Numerical Methods for Engineers. Vol. 2. New York: McGraw-Hill, 1998.
[106] FLUENT, http://www.fluent.com (June, 2016).
[107] Patrachari, Anirudh R., Jagdeep T. Podichetty, and Sundararajan V. Madihally. Application of computational fluid dynamics in tissue engineering. Journal of Bioscience and Bioengineering 114.2: 123-132, 2012.
[108] Yan, X., X. B. Chen, and D. J. Bergstrom. Modeling of the flow within scaffolds in perfusion bioreactors. American Journal of Biomedical Engineering 1.2: 72-77, 2011.
[109] McCoy, Ryan J., C. Jungreuthmayer, and Fergal J. O'Brien. Influence of flow rate and scaffold pore size on cell behavior during mechanical stimulation in a flow perfusion bioreactor. Biotechnology and Bioengineering 109.6: 1583-1594, 2012.
[110] Lovett, M., Rockwood, D., Baryshyan, A., Kaplan, D.L., Simple modular bioreactors for tissue engineering: a system for characterization of oxygen gradients, human mesenchymal stem cell differentiation, and prevascularization, Tissue Engineering Part C, Methods, 16, 1565-73, 2010.
[111] Andrade Jr, J. S., et al. Fluid flow through porous media: the role of stagnant zones. Physical Review Letters 79.20: 3901, 1997.
[112] Pollack, S. R., et al. Numerical model and experimental validation of microcarrier motion in a rotating bioreactor. Tissue Engineering 6.5: 519-530, 2000.
[113] Williams, Kenneth A., Sunil Saini, and Timothy M. Wick. Computational Fluid Dynamics Modeling of Steady‐State Momentum and Mass Transport in a Bioreactor for Cartilage Tissue Engineering. Biotechnology Progress 18.5: 951-963, 2002.
[114] Lappa, Marcello. A CFD level-set method for soft tissue growth: theory and fundamental equations. Journal of Biomechanics 38.1: 185-190, 2005.
[115] Singh, Harmeet, et al. Flow modelling within a scaffold under the influence of uni-axial and bi-axial bioreactor rotation. Journal of Biotechnology 119.2: 181-196, 2005.
[116] Bueno, Ericka M., Bahar Bilgen, and Gilda A. Barabino. Wavy-walled bioreactor supports increased cell proliferation and matrix deposition in engineered cartilage constructs. Tissue Engineering 11.11-12: 1699-1709, 2005.
[117] Boschetti, Federica, et al. Prediction of the micro-fluid dynamic environment imposed to three-dimensional engineered cell systems in bioreactors. Journal of Biomechanics 39.3: 418-425, 2006.
[118] Ye, Hua, et al. Modelling nutrient transport in hollow fibre membrane bioreactors for growing three-dimensional bone tissue. Journal of Membrane Science 272.1: 169-178, 2006.
[119] Dusting, Jonathan, John Sheridan, and Kerry Hourigan. A fluid dynamics approach to bioreactor design for cell and tissue culture. Biotechnology and Bioengineering 94.6: 1196-1208, 2006.
[120] Cheng, Gang, et al. Cell population dynamics modulate the rates of tissue growth processes. Biophysical Journal 90.3 2006: 713-724, 2006.
[121] Bilgen, B., Barabino, G.A., Location of scaffolds in bioreactors modulates the hydrodynamic environment experienced by engineered tissues, Biotechnology and Bioengineering, 98, 282-94, 2007.
[122] Galbusera, F., et al. Computational modeling of combined cell population dynamics and oxygen transport in engineered tissue subject to interstitial perfusion. Computer Methods in Biomechanics and Biomedical Engineering 10.4: 279-287, 2007.
[123] Lemon, G., and J. R. King. Multiphase modelling of cell behaviour on artificial scaffolds: effects of nutrient depletion and spatially nonuniform porosity. Mathematical Medicine and Biology 24.1: 57-83, 2007.
[124] Maes, Frédéric, et al. Modeling fluid flow through irregular scaffolds for perfusion bioreactors. Biotechnology and Bioengineering 103.3: 621-630, 2009.
[125] Hidalgo‐Bastida, L. Araida, et al. Modeling and design of optimal flow perfusion bioreactors for tissue engineering applications. Biotechnology and Bioengineering 109.4: 1095-1099, 2012.
[126] Liovic, Petar, et al. Fluid flow and stresses on microcarriers in spinner flask bioreactors. Proceedings of the 9th International Conference on CFD in the Minerals and Process Industries, 2012.
